Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Re..Repurposed Drugs

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Jun 21, 2024 10:49am

190 Views

Post# 36099903

RE:RE:Re..Repurposed Drugs

Fluorine gaz is deadly, yet we use fluoride in toothpaste everyday and it's safe. Same difference between pure or radioactive isotope of Ruthenium vs Ruvidar or Rutherin. A little chemical modification can render a poison into a life saving molecule.

Alamir1111 wrote: Good question Tarbaby this is what internet showing

Ruthenium compounds, such as ruthenium (IV) oxide, as considered highly toxic to humans and potential carcinogens (i.e., can cause the development of cancers). Radioisotopes of ruthenium, primarily Ru-106, are also dangerous to humans and exposure can increase one's risk of developing cancers.